Murielle Combettes

Summary

Affiliation: Institut de Recherches Servier
Country: France

Publications

  1. ncbi request reprint Newly approved and promising antidiabetic agents
    Murielle Combettes
    Institut de Recherches Servier, Suresnes, France
    Therapie 62:293-310. 2007
  2. ncbi request reprint GLP-1 and type 2 diabetes: physiology and new clinical advances
    Murielle M J Combettes
    Servier, Institut de Recherches Servier, Division Maladies Métaboliques, 11 rue des Moulineaux, 92150 Suresnes, France
    Curr Opin Pharmacol 6:598-605. 2006
  3. pmc Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans
    Frederic De Ceuninck
    Division of Metabolic Diseases, Institut de Recherches Servier, Suresnes, France
    Br J Pharmacol 168:339-53. 2013

Detail Information

Publications3

  1. ncbi request reprint Newly approved and promising antidiabetic agents
    Murielle Combettes
    Institut de Recherches Servier, Suresnes, France
    Therapie 62:293-310. 2007
    ....
  2. ncbi request reprint GLP-1 and type 2 diabetes: physiology and new clinical advances
    Murielle M J Combettes
    Servier, Institut de Recherches Servier, Division Maladies Métaboliques, 11 rue des Moulineaux, 92150 Suresnes, France
    Curr Opin Pharmacol 6:598-605. 2006
    ..To take advantage of the multifaceted actions of GLP-1, a better understanding of the physiological roles of GLP-1 is required...
  3. pmc Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans
    Frederic De Ceuninck
    Division of Metabolic Diseases, Institut de Recherches Servier, Suresnes, France
    Br J Pharmacol 168:339-53. 2013
    ..Because liver overexpression of glucokinase is thought to be associated with altered lipid profiles, this study aimed at assessing the potential lipogenic risks linked to oral GKA administration...